These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 8899132

  • 1. The oral dose-effect relationship for fluvoxamine: a fixed-dose comparison against placebo in depressed outpatients.
    Walczak DD, Apter JT, Halikas JA, Borison RL, Carman JS, Post GL, Patrick R, Cohn JB, Cunningham LA, Rittberg B, Preskorn SH, Kang JS, Wilcox CS.
    Ann Clin Psychiatry; 1996 Sep; 8(3):139-51. PubMed ID: 8899132
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders.
    Sonawalla SB, Spillmann MK, Kolsky AR, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M.
    J Clin Psychiatry; 1999 Sep; 60(9):580-3. PubMed ID: 10520975
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.
    Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.
    J Clin Psychiatry; 2004 Oct; 65(10):1356-64. PubMed ID: 15491239
    [Abstract] [Full Text] [Related]

  • 4. Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression.
    Feighner JP, Overø K.
    J Clin Psychiatry; 1999 Dec; 60(12):824-30. PubMed ID: 10665628
    [Abstract] [Full Text] [Related]

  • 5. Fluvoxamine versus imipramine and placebo: a double-blind comparison in depressed patients.
    Fabre L, Birkhimer LJ, Zaborny BA, Wong LF, Kapik BM.
    Int Clin Psychopharmacol; 1996 Jun; 11(2):119-27. PubMed ID: 8803649
    [Abstract] [Full Text] [Related]

  • 6. Antidepressant efficacy in relation to item analysis and severity of depression: a placebo-controlled trial of fluvoxamine versus imipramine.
    Kasper S, Möller HJ, Montgomery SA, Zondag E.
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():3-12. PubMed ID: 7622821
    [Abstract] [Full Text] [Related]

  • 7. Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.
    Claghorn JL, Earl CQ, Walczak DD, Stoner KA, Wong LF, Kanter D, Houser VP.
    J Clin Psychopharmacol; 1996 Apr; 16(2):113-20. PubMed ID: 8690826
    [Abstract] [Full Text] [Related]

  • 8. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.
    Burke WJ, Gergel I, Bose A.
    J Clin Psychiatry; 2002 Apr; 63(4):331-6. PubMed ID: 12000207
    [Abstract] [Full Text] [Related]

  • 9. A double-blind comparison of nefazodone, imipramine, and placebo in major depression.
    Fontaine R, Ontiveros A, Elie R, Kensler TT, Roberts DL, Kaplita S, Ecker JA, Faludi G.
    J Clin Psychiatry; 1994 Jun; 55(6):234-41. PubMed ID: 8071277
    [Abstract] [Full Text] [Related]

  • 10. Venlafaxine versus fluvoxamine in the treatment of delusional depression: a pilot double-blind controlled study.
    Zanardi R, Franchini L, Serretti A, Perez J, Smeraldi E.
    J Clin Psychiatry; 2000 Jan; 61(1):26-9. PubMed ID: 10695642
    [Abstract] [Full Text] [Related]

  • 11. A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients.
    Kiev A, Feiger A.
    J Clin Psychiatry; 1997 Apr; 58(4):146-52. PubMed ID: 9164424
    [Abstract] [Full Text] [Related]

  • 12. A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder.
    Hollander E, Koran LM, Goodman WK, Greist JH, Ninan PT, Yang H, Li D, Barbato LM.
    J Clin Psychiatry; 2003 Jun; 64(6):640-7. PubMed ID: 12823077
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder.
    Silverstone PH, Salinas E.
    J Clin Psychiatry; 2001 Jul; 62(7):523-9. PubMed ID: 11488362
    [Abstract] [Full Text] [Related]

  • 14. Paroxetine versus placebo: a double-blind comparison in depressed patients.
    Claghorn JL, Kiev A, Rickels K, Smith WT, Dunbar GC.
    J Clin Psychiatry; 1992 Dec; 53(12):434-8. PubMed ID: 1487471
    [Abstract] [Full Text] [Related]

  • 15. Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: a comparison of venlafaxine, selective serotonin reuptake inhibitors, and placebo.
    Mallick R, Chen J, Entsuah AR, Schatzberg AF.
    J Clin Psychiatry; 2003 Mar; 64(3):321-30. PubMed ID: 12716275
    [Abstract] [Full Text] [Related]

  • 16. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ, Jiang Q.
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [Abstract] [Full Text] [Related]

  • 17. Fluvoxamine as effective as clomipramine against symptoms of severe depression: results from a multicentre, double-blind study.
    Zohar J, Keegstra H, Barrelet L.
    Hum Psychopharmacol; 2003 Mar; 18(2):113-9. PubMed ID: 12590404
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial.
    Keller MB, Ryan ND, Strober M, Klein RG, Kutcher SP, Birmaher B, Hagino OR, Koplewicz H, Carlson GA, Clarke GN, Emslie GJ, Feinberg D, Geller B, Kusumakar V, Papatheodorou G, Sack WH, Sweeney M, Wagner KD, Weller EB, Winters NC, Oakes R, McCafferty JP.
    J Am Acad Child Adolesc Psychiatry; 2001 Jul; 40(7):762-72. PubMed ID: 11437014
    [Abstract] [Full Text] [Related]

  • 19. Two items on the Hamilton Depression rating scale are effective predictors of remission: comparison of selective serotonin reuptake inhibitors with the combined serotonin/norepinephrine reuptake inhibitor, venlafaxine.
    Silverstone PH, Entsuah R, Hackett D.
    Int Clin Psychopharmacol; 2002 Nov; 17(6):273-80. PubMed ID: 12409680
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients in menopause transition.
    Ushiroyama T, Ikeda A, Ueki M.
    J Med; 2004 Nov; 35(1-6):151-62. PubMed ID: 18084873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.